Results 1 to 10 of about 25,481 (162)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures

open access: yesMolecules, 2018
Pharmacophore modeling is a widely used strategy for finding new hit molecules. Since not all protein targets have available 3D structures, ligand-based approaches are still useful. Currently, there are just a few free ligand-based pharmacophore modeling
Alina Kutlushina   +3 more
doaj   +6 more sources

Pharmacophore modeling: advances and pitfalls [PDF]

open access: yesFrontiers in Molecular Biosciences
Pharmacophore modeling has evolved from a static conceptual framework into a central computational tool in modern drug discovery. Recent advances include multi-pharmacophore strategies that better capture ligand diversity and target flexibility, as well ...
Mahmoud Y. Elsaka   +8 more
doaj   +2 more sources

AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases

open access: yesActa Pharmaceutica Sinica B, 2021
We herein describe AncPhore, a versatile tool for drug discovery, which is characterized by pharmacophore feature analysis and anchor pharmacophore (i.e., most important pharmacophore features) steered molecular fitting and virtual screening. Comparative
Qingqing Dai   +7 more
doaj   +3 more sources

PharmacoForge: pharmacophore generation with diffusion models [PDF]

open access: yesFrontiers in Bioinformatics
Structure-based drug design (SBDD) is enhanced by machine learning (ML) to improve both virtual screening and de novo design. Despite advances in ML tools for both strategies, screening remains bounded by time and computational cost, while generative ...
Emma L. Flynn   +7 more
doaj   +2 more sources

Palladium Complexes Catalysed Telomerisation of Arylamines with Butadiene and Their Cyclisation into Quinoline Derivatives

open access: yesBulletin of Chemical Reaction Engineering & Catalysis, 2022
Since alkynyl-arylamines are widely used in the chemical industry as pre products, a method of catalytic synthesis of problematic substituted quinolines from aromatic amines containing octadienal substituents has been developed.
Ramil Zaripov   +5 more
doaj   +1 more source

Pharmacophore Modeling in Drug Discovery: Methodology and Current Status

open access: yesJournal of the Turkish Chemical Society, Section A: Chemistry, 2021
A pharmacophore describes the framework of molecular features that are vital for the biological activity of a compound. Pharmacophore models are built by using the structural information about the active ligands or targets.
Muhammed Tilahun MUHAMMED   +1 more
doaj   +1 more source

Toll-like receptor 7 agonists: chemical feature based pharmacophore identification and molecular docking studies. [PDF]

open access: yesPLoS ONE, 2013
Chemical feature based pharmacophore models were generated for Toll-like receptors 7 (TLR7) agonists using HypoGen algorithm, which is implemented in the Discovery Studio software.
Hui Yu   +6 more
doaj   +1 more source

Towards a partial order graph for interactive pharmacophore exploration: extraction of pharmacophores activity delta

open access: yesJournal of Cheminformatics, 2023
This paper presents a novel approach called Pharmacophore Activity Delta for extracting outstanding pharmacophores from a chemogenomic dataset, with a specific focus on a kinase target known as BCR-ABL.
Etienne Lehembre   +10 more
doaj   +1 more source

Applications of the Novel Quantitative Pharmacophore Activity Relationship Method QPhAR in Virtual Screening and Lead-Optimisation

open access: yesPharmaceuticals, 2022
Pharmacophores are an established concept for the modelling of ligand–receptor interactions based on the abstract representations of stereoelectronic molecular features.
Stefan Michael Kohlbacher   +3 more
doaj   +1 more source

A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors. [PDF]

open access: yesPLoS ONE, 2013
Inhibition of chymase is likely to divulge therapeutic ways for the treatment of cardiovascular diseases, and fibrotic disorders. To find novel and potent chymase inhibitors and to provide a new idea for drug design, we used both ligand-based and ...
Mahreen Arooj   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy